Lipoprotein(a) and the risk of cardiovascular disease in the European population: results from the BiomarCaRE consortium

Abstract

In this large dataset on harmonized Lp(a) determination, we observed regional differences within the European population. Elevated Lp(a) was robustly associated with an increased risk for MCE and CVD in particular among individuals with diabetes. These results may lead to better identification of target populations who might benefit from future Lp(a)-lowering therapies.